Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial - Intensive Treatment Based in Ivermectin and Iota-carrageenan as Prophylaxis for Covid-19 In Healthcare Agents

NCT04701710 is registered in ClinicalTrials.gov with Maria de los Angeles Peral de Bruno as lead sponsor.

NCT NCT04701710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04701710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial - Intensive Treatment Based in Ivermectin and Iota-carrageenan as Prophylaxis for Covid-19 In Healthcare Agents
Lead sponsor
Maria de los Angeles Peral de Bruno
Phase
Phase 1/2
Overall status
Completed
Start date
October 15, 2020
Completion date
December 31, 2020
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars (severe acute respiratory syndrome)